Euronext N.V. (EPA:ENX)
France flag France · Delayed Price · Currency is EUR
148.30
-1.30 (-0.87%)
Jul 8, 2026, 5:35 PM CET

Euronext Earnings Call Transcripts

Fiscal Year 2026

  • AGM 2026

    Double-digit revenue and income growth, a 10% dividend increase, and major strategic milestones were achieved, including CSD expansion and new product launches. All voting items, including board appointments and share buybacks, were approved by large majorities. Management reaffirmed commitment to governance, risk management, and further European consolidation.

  • Record Q1 2026 results with double-digit growth in revenue, EBITDA, and EPS, driven by diversified revenue streams, strategic expansion, and strong market activity. Robust cash flow, disciplined cost management, and continued investments support a positive outlook.

Fiscal Year 2025

  • Double-digit growth in revenue, EBITDA, and EPS was achieved in 2025, driven by both volume and non-volume-related businesses, with strong contributions from recent acquisitions and strategic initiatives. The outlook remains robust, with continued investment in growth and favorable market conditions.

  • Q3 2025 saw double-digit revenue growth, record assets under custody, and strong EBITDA margin gains, driven by both volume and non-volume-related businesses. Upgraded cost guidance and a EUR 250 million share buyback reflect robust financial health, while strategic initiatives and M&A activity continue to advance.

  • Q2 2025 saw record results with revenue up 12.8% year-over-year, strong growth across all segments, and continued double-digit top-line expansion. Strategic acquisitions, including ATHEX and Admincontrol, further diversified operations, while cost guidance and synergy targets remain on track.

  • AGM 2025

    The meeting confirmed strong financial growth, a higher dividend, and the adoption of strategic initiatives for 2027. Shareholders rejected the 2024 remuneration report over governance concerns, but approved all other proposals, including board appointments and policy amendments.

  • Q1 2025 saw 14.1% revenue growth, driven by strong non-volume and volume-related activities, with adjusted EBITDA up 17% and net income up 17.9%. Strategic initiatives, acquisitions, and market volatility supported performance, while cost discipline and capital allocation remain priorities.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018